Lipidemic Profile Changes over a Two-Year Intervention Period: Who Benefited Most from the Feel4Diabetes Program?


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
04 Dec 2020
Historique:
received: 18 11 2020
accepted: 30 11 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 10 4 2021
Statut: epublish

Résumé

Identification of participants' characteristics who benefited most from large community-based intervention studies may guide future prevention initiatives in order to maximize their effectiveness. The current study aimed to examine the socio-demographic, anthropometric, and behavioral characteristics, as well as the health and eating perceptions of those who improved their lipidemic profile, in the Feel4Diabetes early screening and prevention program. In the present analyses, 1773 adults from families at high risk for developing type 2 diabetes mellitus (T2DM) were enrolled, receiving either the standard care or the more intensive intervention, and 33.3-55.2% of them improved one or more of their lipidemic indices by >5%. Women, people living in Southeastern Europe, coming from two-parent families, having higher financial security, educational level and better diet quality were associated with a 27-64% higher likelihood for benefiting from the program regarding one or more of their lipidemic profile indices. Participants who were overweight or obese (especially with central obesity), employed, with prolonged sedentary behavior, prone to emotional eating and perceiving their weight status as lower than their actual weight were 24-43% less likely to have benefited. These findings should guide future interventions, prioritizing regions in greater need, and being tailor-made to specific population characteristics in order to further improve their effectiveness.

Identifiants

pubmed: 33291645
pii: nu12123736
doi: 10.3390/nu12123736
pmc: PMC7761911
pii:
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Horizon 2020
ID : 643708

Références

Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
BMC Public Health. 2013 Mar 11;13:219
pubmed: 23497156
PLoS Med. 2009 Apr 28;6(4):e1000058
pubmed: 19399161
Pharmacol Res. 2018 Aug;134:51-60
pubmed: 29859248
Eur J Prev Cardiol. 2016 Dec;23(18):2007-2018
pubmed: 27638542
N Engl J Med. 2011 Nov 24;365(21):1959-68
pubmed: 22085317
Int Health. 2019 Nov 06;:
pubmed: 31693111
Vasc Health Risk Manag. 2011;7:67-74
pubmed: 21415919
Obes Rev. 2017 Oct;18(10):1200-1209
pubmed: 28730613
Diabetes Res Clin Pract. 2011 Jan;91(1):1-12
pubmed: 20655610
J Med Internet Res. 2016 Nov 09;18(11):e278
pubmed: 27829576
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
BMJ. 2014 Jun 09;348:g3617
pubmed: 24912589
J Med Internet Res. 2018 Apr 18;20(4):e122
pubmed: 29669703
BMC Public Health. 2014 Aug 28;14:782
pubmed: 25179437
Curr Opin Lipidol. 2015 Dec;26(6):566-71
pubmed: 26780009
Scand J Public Health. 2006;34(5):453-61
pubmed: 16990155
Hormones (Athens). 2018 Mar;17(1):61-67
pubmed: 29858856
Vasc Health Risk Manag. 2009;5:757-65
pubmed: 19774217
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
CMAJ. 2007 Oct 9;177(8):859-65
pubmed: 17923653
Public Health Nutr. 2018 Dec;21(17):3281-3290
pubmed: 30207513
Int J Epidemiol. 2011 Jun;40(3):804-18
pubmed: 21335614
Int J Behav Nutr Phys Act. 2011 Mar 22;8:20
pubmed: 21426567
Diabetes Care. 2003 Mar;26(3):725-31
pubmed: 12610029
BMC Endocr Disord. 2020 Mar 12;20(Suppl 1):12
pubmed: 32164646
Diabet Med. 2013 Jan;30(1):16-25
pubmed: 23002995
Diabetologia. 2015 May;58(5):886-99
pubmed: 25725623
Am J Clin Nutr. 2008 May;87(5):1107-17
pubmed: 18469226

Auteurs

Kalliopi Karatzi (K)

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece.

George Moschonis (G)

Department of Dietetics, Nutrition and Sport, School of Allied Health, Human Services and Sport, La Trobe University, Melbourne, VIC 3086, Australia.

Eirini Botsi (E)

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece.

Stavros Liatis (S)

National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece.

Kaloyan Tsochev (K)

Department of Paediatrics, Medical University Varna, 9002 Varna, Bulgaria.

Pilar De Miguel-Etayo (P)

Growth, Exercise, Nutrition and Development (GENUD) Research Group, Instituto Agroalimentario de Aragón (IA2), Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Universidad de Zaragoza, 50009 Zaragoza, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Jemina Kivelä (J)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.

Katja Wikström (K)

Department of Public Health Solutions, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.

Roumyana Dimova (R)

Department of Diabetology, Clinical Center of Endocrinology, Medical University Sofia, 1431 Sofia, Bulgaria.

Emese Antal (E)

Hungarian Society of Nutrition, 1088 Budapest, Hungary.

Itziar Lamiquiz-Moneo (I)

Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), CIBERCV, Universidad de Zaragoza, 50009 Zaragoza, Spain.

Imre Rurik (I)

Hungarian Society of Nutrition, 1088 Budapest, Hungary.

Greet Cardon (G)

Department of Movement and Sports Sciences, Faculty of Medicine and Health Sciences, Ghent University, 9000 Gent, Belgium.

Violeta Iotova (V)

Department of Paediatrics, Medical University Varna, 9002 Varna, Bulgaria.

Konstantinos Makrilakis (K)

National and Kapodistrian University of Athens Medical School, 11527 Athens, Greece.

Yannis Manios (Y)

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH